Penumbra
PEN
$205.50
Share price
-0.32%
Change (1 day)
-27.87%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Revenue for Penumbra (PEN)
Revenue in 2023 (TTM): $1.05 B
According to Penumbra's latest financial reports the company's current revenue (TTM) is $1.05 B. In 2022 the company made a revenue of $0.84 B an increase over the years 2021 revenue that were of $0.74 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Penumbra from 2015 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1.05 B | 24.95% |
| 2022 | $0.84 B | 13.32% |
| 2021 | $0.74 B | 33.4% |
| 2020 | $0.56 B | 2.38% |
| 2019 | $0.54 B | 23.03% |
| 2018 | $0.44 B | 33.31% |
| 2017 | $0.33 B | 26.75% |
| 2016 | $0.26 B | 41.5% |
| 2015 | $0.18 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | $1.25 B | 18.79% | 🇺🇸 USA |
 Inari Medical
NARI | $0.49 B | -53.37% | 🇺🇸 USA |